Spinal cord repair: could cell injections restore function in transverse myelitis?
Disease control
Recruiting now
This early-stage trial tests the safety of injecting Q-Cells, a type of human glial progenitor cell, directly into spinal cord lesions in people with transverse myelitis. The study enrolls up to 9 adults aged 18–70 who have had the condition for at least 3 months. Researchers wil…
Phase: PHASE1, PHASE2 • Sponsor: Q Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC